Coalition: Advocacy for Prospective Clinical Trials to Test the Post-Exposure Potential of Hydroxychloroquine Against COVID-19

Picot, Stephane; Marty, Aileen; Bienvenu, Anne-Lise; Blumberg, Lucille H.; Dupouy-Camet, Jean; Carnevale, Pierre; Kano, Shigeyuki; Jones, Malcolm K.; Daniel-Ribeiro, Cláudio Tadeu; MasComa, Santiago

This article is a Preprint

Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.

Coalition: Advocacy for Prospective Clinical Trials to Test the Post-Exposure Potential of Hydroxychloroquine Against COVID-19

Picot, Stephane; Marty, Aileen; Bienvenu, Anne-Lise; Blumberg, Lucille H.; Dupouy-Camet, Jean; Carnevale, Pierre; Kano, Shigeyuki; Jones, Malcolm K.; Daniel-Ribeiro, Cláudio Tadeu; MasComa, Santiago.

Affiliation

Picot, Stephane; University Lyon. Malaria Research Unit. ICBMS. UMR 5246 CNRS INSA CPE. Lyon, France / Croix-Rousse Hospital. Hospices Civils de LyonInstitute of Parasitology and Medical Mycology. Lyon, France..

Elsevier; .

Preprint in En | PREPRINT-FIOCRUZ | ID: ppf-40858